About Kevin McDonald
Kevin McDonald is managing director of K. McDonald & Co and a partner at McDonald Lehner. Earlier, he was chief executive officer of the Defense Enterprise Fund and senior advisor to the U.S. Department of State. He is also a director of Mercury Bio, which develops medicines targeting cellular disease processes in Parkinson’s and Alzheimer’s disease.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Kevin McDonald in the role, so the role may have started earlier or lasted longer.
Mercury Bio, Inc. Current
Director
2023 – Present · Santa Fe, NM
Mercury Bio develops precision medicines that carry therapeutic cargo into cells affected by Parkinson’s and Alzheimer’s disease.
KC
K. McDonald & Co Current
Managing Director
ML
McDonald Lehner Current
Partner
DF
Defense Enterprise Fund
CEO
US
U.S. Dept. of State
Senior Advisor
Key Colleagues at Startups
The people Kevin McDonald works with at each company, as listed on that company's latest Form D.
Mercury Bio, Inc. · Form D, Nov 13, 2026
SK
Steve Kiziuk
CEO, Mountain Vector Energy and director
AK
Alex Koglin
Director
Dana Barnard
Chairman of the Board
BM
Bruce McCormick
Chief Executive Officer and director
MR
Mike Rice
Director
JT
John Tomes
Director of Finance, Mercury Bio
BS
Bryan Scheer
CEO, InREACH HEALTHCARE & ADVA CERA, director
Telemetry Insight Inc · Form D, Oct 23, 2025
SB
Shelley Barratt
Executive officer
RK
Randolph Krall
CEO and director
CL
Cliff Lewis
Executive officer
TC
Tony Carrato
Director
AB
Arjun Bhakta
Executive officer